Loyal

Loyal is a US-based company focused on innovative pharmaceuticals that enhance the health and longevity of dogs, primarily through its flagship anti-aging product, LOY-002, designed for senior canines. Founded in 2020 in San Francisco, US, Loyal Animal Health, Inc. specializes in developing veterinary pharmaceuticals. The company has raised a total of USD 22.

175 mn, receiving backing from investors such as Collaborative Fund and Valor Equity Partners in its most recent funding round, Series B, on October 11, 2024. The founder, Celine Halioua, has a history of entrepreneurship, leading Loyal's mission to improve canine health. Loyal Animal Health, Inc. specializes in developing innovative pharmaceuticals aimed at extending the healthy lifespan of dogs through its flagship product, LOY-002.

This anti-aging pill for senior dogs is the first to undergo a pivotal clinical study supported by the FDA. The company's product line also includes LOY-001 and LOY-003, which target longevity across various dog breeds. Loyal serves veterinarians, pet owners, and animal health distributors, particularly in North America and Europe, focusing on improving health outcomes for aging dogs. Loyal Animal Health generates revenue through direct-to-consumer sales and B2B partnerships with veterinary clinics and animal health retailers.

The company utilizes a subscription model for ongoing supply agreements, though specific pricing details for LOY-002 are not disclosed. This revenue structure fosters long-term relationships with veterinary professionals, vital for recommending its health solutions to pet owners. Following the latest funding round of USD 22. 17 mn, part of a broader USD 45 mn Series B, Loyal plans to enhance operations and invest in research and development.

Upcoming products are anticipated to be launched, although specific details on new product release dates are currently unavailable. The company aims to expand into additional markets, specifically targeting regions in North America and Europe for growth by enhancing its market presence and product offerings.